首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   7221篇
  免费   438篇
  国内免费   57篇
耳鼻咽喉   63篇
儿科学   294篇
妇产科学   239篇
基础医学   761篇
口腔科学   153篇
临床医学   1248篇
内科学   1054篇
皮肤病学   78篇
神经病学   575篇
特种医学   221篇
外科学   695篇
综合类   79篇
一般理论   11篇
预防医学   1058篇
眼科学   99篇
药学   576篇
中国医学   13篇
肿瘤学   499篇
  2023年   30篇
  2022年   25篇
  2021年   92篇
  2020年   74篇
  2019年   127篇
  2018年   157篇
  2017年   109篇
  2016年   119篇
  2015年   153篇
  2014年   224篇
  2013年   315篇
  2012年   461篇
  2011年   497篇
  2010年   337篇
  2009年   235篇
  2008年   468篇
  2007年   519篇
  2006年   536篇
  2005年   489篇
  2004年   472篇
  2003年   459篇
  2002年   499篇
  2001年   106篇
  2000年   102篇
  1999年   88篇
  1998年   80篇
  1997年   82篇
  1996年   47篇
  1995年   60篇
  1994年   53篇
  1993年   40篇
  1992年   42篇
  1991年   41篇
  1990年   34篇
  1989年   31篇
  1988年   39篇
  1987年   32篇
  1986年   32篇
  1985年   33篇
  1984年   31篇
  1983年   36篇
  1982年   30篇
  1981年   28篇
  1980年   25篇
  1979年   24篇
  1978年   22篇
  1977年   22篇
  1976年   18篇
  1974年   33篇
  1971年   16篇
排序方式: 共有7716条查询结果,搜索用时 31 毫秒
1.

Purpose

Anorexia nervosa (AN) is a chronic and life-threatening eating disorder that can have a considerable negative impact on the growing skeleton. We hypothesized that the long-term impact on bone health may persist even after normalization of body weight.

Methods

41 females (mean age 21.2 ± 2.9 years) with a history of adolescent-onset AN attended a follow-up bone health assessment at 5 years (T5, n?=?28) or 10 years (T10, n?=?13) after their first AN-related hospital admission. Assessment included dual-energy x-ray absorptiometry measurements of the total body, lumbar spine, and proximal femur, peripheral quantitative computed tomography at the radius and tibia, anthropometric measurements, serum biochemistry, fracture history, and a patient questionnaire.

Results

A recovery in body weight and BMI was seen for both the T5 and T10 cohorts (BMI at intake 16.6, BMI at T5-T10 21.2-21.3). Dual-energy x-ray absorptiometry body composition indicated a recovery of fat mass and lean tissue mass. Total BMD was unaffected, but reductions were seen at the femoral neck and arms. Peripheral quantitative computed tomography showed reduced trabecular and cortical bone in the radius, and cortical thinning in the tibia. AN patients showed a statistically significant reduction in measures of radiographic bone health at follow up, although not to a degree that necessitated clinical intervention. Serum insulin-like growth factor 1 was also positively correlated with total BMD and BMC measures. While fracture risk was not increased, a subset of participants (8%) showed multiple (>4) fractures.

Conclusion

A longitudinal study of adolescent AN showed persisting negative effects on bone health.  相似文献   
2.
Background

The purpose of this consensus guideline is to outline recommendations for genetic testing that medical professionals can use to assess hereditary risk for breast cancer.

Methods

Literature review included large datasets, basic and clinical science publications, and recent updated national guidelines. Genetic testing to assess hereditary risk of cancer is a complex, broad, and dynamic area of medical research. The dominant focus of this guideline is limited in scope to breast cancer.

Results

There is a lack of consensus among experts regarding which genes among many should be tested in different clinical scenarios. There is also variation in the degree of consensus regarding the understanding of risk and appropriate clinical management of mutations in many genes.

Conclusions

Genetic testing should be made available to all patients with a personal history of breast cancer. Recent data are reviewed that support genetic testing being offered to each patient with breast cancer (newly diagnosed or with a personal history). If genetic testing is performed, such testing should include BRCA1/BRCA2 and PALB2, with other genes as appropriate for the clinical scenario and family history. For patients with newly diagnosed breast cancer, identification of a mutation may impact local treatment recommendations. Patients who had genetic testing previously may benefit from updated testing. Genetic testing should be made available to patients without a history of breast cancer who meet National Comprehensive Cancer Network guidelines. Finally, variants of uncertain significance are not clinically actionable and these patients should be managed based on their individual risk factors.

  相似文献   
3.
4.
5.
6.
7.
8.
9.
10.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号